Cancer can strike any gender or age group and is a diagnosis that is dreaded by all. The team at ICCA is here to offer help. The ICCA Philosophy is simple; Restore Hope and Restore Life to our patients. Our centers employ therapies that effectively treat the cancer tumor cells without compromising the patient's quality of life in the process.

At ICCA our physicians and team care, be assured, they are highly trained and board certified in their respective subspecialties to employ safe and effective cancer treatments which have undergone rigorous clinical trials and studies in many global medical venues such as Germany, United States, Canada, Cuba, United Kingdom, South Korea, China and of course Mexico (National Cancer Institute), among others.

Integrative Cancer Centers of America ("ICCA") offers Intra-tumoral Immunotherapy, a "tumor-busting" cancer therapy designed to destroy (debulk, shrink, reduce, or neutralize) primary and secondary (metastatic) tumors, even when considered "inoperable" by most other cancer centers.

The aim of cancer immunotherapy is to harness, strengthen, and sustain the power of the immune system to fight cancer. Intra-tumoral Immunotherapy provides several advantages over conventional cancer Immunotherapy strategies.

Though not as well-known as chemotherapy and radiation, immunotherapy actually predates both of these cancer treatments. It was, in fact, the first non-surgical treatment of cancer. Intra-tumoral immunotherapy is a therapeutic strategy which aims to use the tumor as its own vaccine. Upon direct injections into the tumor, a high concentration of immune-stimulatory products can be achieved in situ, while using a small amounts of drugs. Cancer immunotherapy focused on the immune system is often more targeted than chemotherapy or radiation and offers the possibility for long-term control of cancer.

Treatments are typically administered once a week for three or four consecutive weeks; takes less than 45 minutes to perform; are minimally invasive; and generally cause few, if any side-effects.

If you or a loved one is facing a treatment decision, losing hope, or looking for alternative treatment options, please take the time to review our website, then call us with any questions.

We're here to help you to understand the unique benefits of Intra-Tumoral Immunotherapy!

Integrative Cancer Centers of America ("ICCA") offers Intra-tumoral Immunotherapy, a "tumor-busting" cancer therapy designed to destroy (debulk, shrink, reduce, or neutralize) primary and secondary (metastatic) tumors, even when considered "inoperable" by most other cancer centers.

Intra-tumoral Immunotherapy is a composition of several government approved oxidants and non-toxic antigen enhancers injected directly into any solid tumor with precision accuracy while under CT guidance. Treatments are typically administered once a week for three or four consecutive weeks; takes less than 45 minutes to perform; is minimally invasive; and generally cause few, if any side-effects.

Intra-tumoral Immunotherapy is designed to serve three vitally important functions:

• Destroy late stage or inoperable tumors without surgery, radiation, or chemotherapy, and without causing collateral damage to surrounding tissue - even when tumor is classified inoperable by many well-intended Comprehensive Cancer Centers.
• Hinder the spreading of cancer cells (metastasis) by administering systemic autologous tumor antigens designed specifically to enhance cancer cell death (apoptosis).
• Enhance Immune Cell Response by administering a systemic dendritic cancer vaccine designed specifically to better identify evasive cancer cells and help destroy, hamper or even reverse progressive tumor growth.

ICCA physicians are highly trained and board certified in their respective sub subspecialties to employ safe and effective cancer treatments which have undergone rigorous clinical trials and studies in many global medical venues such as Germany, United States, Canada, Cuba, United Kingdom, South Korea, China and of course Mexico (National Cancer Institute), among others.

---